Effectiveness and safety of novel oral anticoagulants as compared with vitamin K antagonists in the treatment of acute symptomatic venous thromboembolism: a systematic review and meta-analysis

Systematic Review: Case-Fatality Rates of Recurrent Venous Thromboembolism and Major Bleeding Events Among Patients Treated for Venous Thromboembolism

(2013) Marc Carrier   ANNALS OF INTERNAL MEDICINE

Management and Outcomes of Major Bleeding During Treatment With Dabigatran or Warfarin

(2013) Ammar Majeed et al.   CIRCULATION

Impact of double-blind vs. open study design on the observed treatment effects of new oral anticoagulants in atrial fibrillation: a meta-analysis

(2013) J.-C. Lega et al.   JOURNAL OF THROMBOSIS AND HAEMOSTASIS

Diagnostic management of acute deep vein thrombosis and pulmonary embolism

(2013) M. V. Huisman et al.   JOURNAL OF THROMBOSIS AND HAEMOSTASIS

Edoxaban versus Warfarin for the Treatment of Symptomatic Venous Thromboembolism

(2013)   NEW ENGLAND JOURNAL OF MEDICINE

Extended Use of Dabigatran, Warfarin, or Placebo in Venous Thromboembolism

(2013) Sam Schulman et al.   NEW ENGLAND JOURNAL OF MEDICINE

Oral Apixaban for the Treatment of Acute Venous Thromboembolism

(2013) Giancarlo Agnelli et al.   NEW ENGLAND JOURNAL OF MEDICINE

Do open label blinded outcome studies of novel anticoagulants versus warfarin have equivalent validity to those carried out under double-blind conditions?

(2013) William O’Neil et al.   THROMBOSIS AND HAEMOSTASIS

Efficacy and safety outcomes of oral anticoagulants and antiplatelet drugs in the secondary prevention of venous thromboembolism: systematic review and network meta-analysis

(2013) L. A. Castellucci et al.   BMJ-British Medical Journal

Periprocedural Management and Approach to Bleeding in Patients Taking Dabigatran

(2012) Jeffrey I. Weitz et al.   CIRCULATION

Dabigatran attenuates thrombin generation to a lesser extent than warfarin: could this explain their differential effects on intracranial hemorrhage and myocardial infarction?

(2012) Brian Dale et al.   JOURNAL OF THROMBOSIS AND THROMBOLYSIS

Oral Rivaroxaban for the Treatment of Symptomatic Pulmonary Embolism

(2012)   NEW ENGLAND JOURNAL OF MEDICINE

Efficacy and safety of novel oral anticoagulants for treatment of acute venous thromboembolism: direct and adjusted indirect meta-analysis of randomised controlled trials

(2012) B. D. Fox et al.   BMJ-British Medical Journal

Reversal of Rivaroxaban and Dabigatran by Prothrombin Complex Concentrate

(2011) Elise S. Eerenberg et al.   CIRCULATION

Oral Rivaroxaban for Symptomatic Venous Thromboembolism

(2010)   NEW ENGLAND JOURNAL OF MEDICINE

New oral anticoagulant drugs in cardiovascular disease

(2010) Gregory Lip et al.   THROMBOSIS AND HAEMOSTASIS

Rivaroxaban - an oral, direct Factor Xa inhibitor - lessons from a broad clinical study programme

(2009) Sylvia Haas   EUROPEAN JOURNAL OF HAEMATOLOGY

Dabigatran versus Warfarin in the Treatment of Acute Venous Thromboembolism

(2009) Sam Schulman et al.   NEW ENGLAND JOURNAL OF MEDICINE

Efficacy and safety of the oral direct factorXa inhibitor apixaban for symptomatic deep vein thrombosis. The Botticelli DVT dose-ranging study

(2008) et al.   JOURNAL OF THROMBOSIS AND HAEMOSTASIS